SCHEDULE 13GFiled May 25, 8:00 PM ET
Avalo Therapeutics, Inc. SCHEDULE 13G
Point72 Asset Management, L.P.Summary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.
This filing does not have a generated research summary. You can still open the original filing and its exhibits.